Blockade of chemokine signaling in patients with multiple sclerosis

F Zipp1, H P Hartung, J Hillert

  • 1Institute of Neuroimmunology, Neuroscience Research Center, NWFZ 2680, Charité, 10098 Berlin, Germany. frauke.zipp@charite.de

Neurology
|November 30, 2006
PubMed